-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Abbott Laboratories, Raises Price Target to $120

Benzinga·07/17/2026 14:56:45
Listen to the news
JP Morgan analyst Robbie Marcus maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $110 to $120.